Does SELPERCATINIB Cause Urinary tract infection? 30 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Urinary tract infection have been filed in association with SELPERCATINIB (RETEVMO). This represents 2.8% of all adverse event reports for SELPERCATINIB.
30
Reports of Urinary tract infection with SELPERCATINIB
2.8%
of all SELPERCATINIB reports
1
Deaths
30
Hospitalizations
How Dangerous Is Urinary tract infection From SELPERCATINIB?
Of the 30 reports, 1 (3.3%) resulted in death, 30 (100.0%) required hospitalization.
Is Urinary tract infection Listed in the Official Label?
Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for SELPERCATINIB.
What Other Side Effects Does SELPERCATINIB Cause?
Malignant neoplasm progression (106)
Death (90)
Hypertension (58)
Hypersensitivity (55)
Diarrhoea (54)
Fatigue (51)
Rash (49)
Hepatic function abnormal (42)
Alanine aminotransferase increased (38)
Pyrexia (38)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which SELPERCATINIB Alternatives Have Lower Urinary tract infection Risk?
SELPERCATINIB vs SELUMETINIB
SELPERCATINIB vs SEMAGLUTIDE
SELPERCATINIB vs SEMUSTINE
SELPERCATINIB vs SENNA LEAF
SELPERCATINIB vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B